Navigation Links
FluoroMax multiwavelength capability

Simultaneously monitoring the levels of relevant metabolites and cell parameters is necessary to properly assess the effectiveness of drugs on living cells. The FLUOROMAX spectrofluorometer allows the user to monitor up to eight wavelength-pairs of emission and excitation wavelengths. Coupling this capability with the proper probes can produce a real-time analysis of unfolding biological processes.

One research application that used simultaneous observation of multiple wavelength-pairs was performed by M. Kimura, et al., at the University of Medicine and Dentistry of New Jersey. 1 Their evaluation of Thapsigargin, a hypertensive drug, was performed on a FLUOROMAX spectrofluorometer. The results demonstrated that the effect of the drug in human platelets was not limited to the elevation of the Ca2+ but produced substantial changes in the overall ionic balance.

Figure 1 shows a sample screen display taken from DATAMAX (FLUOROMAX software for Windows). Note how DATAMAX makes the monitoring of up to eight wavelengthpairs a simple matter of selection.

FLUOROMAX, with DATAMAX software, allows the user to monitor wavelengthpairs to characterize processes in living cells and other biological systems. The measurement is feasible in real time because of the FLUOROMAX spectrofluorometers ability to scan rapidly (up to 200 nm s1).

1 Kimura, M.; et al. J. Physiol. 1993, 494, 113.

back to top


Page: All 1

Related biology technology :

1. Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax
2. Near IR capability of the FluoroLog
Post Your Comments:

(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
Breaking Biology News(10 mins):